SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-14-001438
Filing Date
2014-03-27
Accepted
2014-03-27 09:00:30
Documents
20
Period of Report
2014-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_032714.htm 8-K 24891
2 EXHIBIT 99.1 exh_991.htm EX-99.1 33709
3 EXHIBIT 99.2 exh_992.htm EX-99.2 17739
4 exh992_01.jpg GRAPHIC 102049
5 exh992_02.jpg GRAPHIC 193406
6 exh992_03.jpg GRAPHIC 116492
7 exh992_04.jpg GRAPHIC 165893
8 exh992_05.jpg GRAPHIC 184038
9 exh992_06.jpg GRAPHIC 119057
10 exh992_07.jpg GRAPHIC 149668
11 exh992_08.jpg GRAPHIC 127450
12 exh992_09.jpg GRAPHIC 155171
13 exh992_10.jpg GRAPHIC 169926
14 exh992_11.jpg GRAPHIC 173280
15 exh992_12.jpg GRAPHIC 174814
16 exh992_13.jpg GRAPHIC 191721
17 exh992_14.jpg GRAPHIC 174086
18 exh992_15.jpg GRAPHIC 132895
19 exh992_16.jpg GRAPHIC 133886
20 exh992_17.jpg GRAPHIC 118378
  Complete submission text file 0001171843-14-001438.txt   3637391
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33560 | Film No.: 14720225
SIC: 2834 Pharmaceutical Preparations